Abstract

Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Outcomes of First-Line Ibrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and High-Risk Genomic Features with up to 6.5 Years Follow-up: Integrated Analysis of Two Phase 3 Studies (RESONATE-2 and iLLUMINATE)
Jan A Burger ... Alessandra Tedeschi
Blood | VOL. 136
Jan A Burger, et. al.Jan A Burger ... Alessandra Tedeschi
05 Nov 2020
SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine + Rituximab (BR) in Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Constantine S Tam ...
Blood | VOL. 138
Constantine S Tam, et. al.Constantine S Tam ...
05 Nov 2021
Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub-Analysis of the Phase 3 Unity-CLL Study
Ryan Jacobs ...
Blood | VOL. 138
Ryan Jacobs, et. al.Ryan Jacobs ...
05 Nov 2021
Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): 1-Year Disease-Free Survival (DFS) Results From the MRD Cohort of the Phase 2 CAPTIVATE Study
William G Wierda ... Bryone J Kuss
Blood | VOL. 136
William G Wierda, et. al.William G Wierda ... Bryone J Kuss
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Magisetty J, Kondreddy V, Keshava S, et al. Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice. Blood. 2022;139(18):2830-2841.
-
Blood | VOL. 144
--
01 Aug 2024
Human herpesvirus 6 and CAR T-cell toxicity
Karl S Peggs
Blood | VOL. 144
Karl S PeggsKarl S Peggs
01 Aug 2024
EPCR shedding light on sickle nephropathy
Erica M Sparkenbaugh
Blood | VOL. 144
Erica M SparkenbaughErica M Sparkenbaugh
01 Aug 2024
Plasma cells’ fate: it is a complex “orchestra”
Paola Neri
Blood | VOL. 144
Paola NeriPaola Neri
01 Aug 2024
View more papers